Oorsprong van het eerstegraads netwerk van William Brooks
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Quest Management NV
Quest Management NV Investment ManagersFinance Quest Management NV (Quest) is the asset management subsidiary of Capricorn Venture Partners NV in Belgium. Based in Leuven, the firm manages private and public equity investments in European technology and life sciences companies. Quest manages Luxembourg-domiciled funds, in particular a Privak vehicle suited for collective private equity investments and a US dollar-denominated SICAV.
3
| Extinct | Investment Managers | 3 |
Quest Management SA (Private Equity)
Quest Management SA (Private Equity) Investment ManagersFinance Quest Management NV/SA is an independent partner-owned investment management firm specialized in emerging technologies and life sciences. Quest was established in 1998 with the venture capital firm Capricorn Venture Partner as a co-founder, and is located in Leuven in the Flemish region of Belgium. Quest manages Luxembourg-domiciled funds, including a US dollar-denominated SICAV and the Belgian collective private equity investment vehicle Quest for Growth (XB: QFG), which was the first investment company set up as a tax-advantaged Privak.
1
| Extinct | Investment Managers | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met William Brooks via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Capricorn Venture Partners NV (Investment Management)
Capricorn Venture Partners NV (Investment Management) Investment ManagersFinance Capricorn Venture Partners NV (Investment Management) (Capricorn Partners-IM) is the investment management division of Capricorn Venture Partners NV, a private venture company headquartered in Leuven, Belgium. The firm was founded in 1993 as a joint venture between Dr. Jos B. Peeters and Baring Venture Partners Ltd. They were renamed as Capricorn Venture Partners in 2019. Capricorn Partners-IM manages private and public equity investment funds for retail and institutional investors. | Investment Managers | Head-Equity Investments Director/Board Member Director/Board Member | |
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
QUEST FOR GROWTH NV | Investment Managers | President Chief Investment Officer | |
Puilaetco Dewaay Private Bankers SA
Puilaetco Dewaay Private Bankers SA Investment ManagersFinance Puilaetco Dewaay Private Bankers SA (PDPB) is the wholly-owned Belgian private banking subsidiary of KBL European Private Bankers SA, itself a subsidiary of Precision Capital SA in Luxembourg. Created in 2005, the firm is located in Brussels with offices in Antwerp, Knokke and Liège. They provide private banking and asset management services to institutions, corporate clients, high-net worth private individuals and family offices. | Investment Managers | Portfolio Manager-Equities | |
Katholieke Universiteit Leuven | College/University | Undergraduate Degree | |
Abbott Group Ltd.
Abbott Group Ltd. Building ProductsProducer Manufacturing Abbott Group Ltd. manufactures doors and timber products. It specializes in the supply of fenestration products to homebuilders. The company's products include PVC-U windows, doors and cavity closers. Abbott Group is headquartered in Halisham, UK | Building Products | Corporate Officer/Principal | |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director/Board Member | |
KBC Securities NV
KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Investment Banks/Brokers | Analyst-Equity | |
Vrije Universiteit Brussel | College/University | Masters Business Admin | |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director of Finance/CFO | |
QBIC Venture Partners BV
QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Investment Managers | Private Equity Investor | |
Newton Biocapital Partners SRL
Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Investment Managers | Private Equity Investor | |
DeuterOncology SA
DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
België | 12 |
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
Sectoraal
Finance | 8 |
Consumer Services | 3 |
Health Technology | 3 |
Producer Manufacturing | 2 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 7 |
Private Equity Investor | 5 |
Portfolio Manager-Equities | 4 |
Chief Investment Officer | 3 |
President | 3 |
Sterkste connecties
Insiders | |
---|---|
Els Hubloux | 11 |
Yves Vaneerdewegh | 4 |
René Avonts | 4 |
Patrick de Bellefroid | 2 |
- Beurs
- Insiders
- William Brooks
- Bedrijfsconnecties